Alvocidib Hydrochloride

N/A

Report date: 2026/01/25 20:00:09
NME

Base Information

Drug NameAlvocidib Hydrochloride
Drug Alias NameFlavopiridol阿伏西地阿沃西地AlvocidibAlvocidibum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2Cyclin-dependent kinase 9
Therapy Area/IndicationsSkin MelanomaSolid tumoursAngioimmunoblastic T-cell Lymphoma +[76] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharma America IncSanofiBarbara Ann Karmanos Cancer Institute +[8] 
Active IndicationsN/A
Inactive IndicationsSkin MelanomaSolid tumoursAngioimmunoblastic T-cell Lymphoma +[76] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG